Skip Navigation
Markets
Pre-Markets
U.S. Markets
Currencies
Prediction Markets
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs
Business
Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Investigations
Industrials
Retail
Wealth
Sports
Life
Small Business
Investing
Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk
Tech
Cybersecurity
AI
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide
Politics & Policy
White House
Policy
Defense
Congress
Expanding Opportunity
Video
Latest Video
Full Episodes
Livestream
Live Audio
Live TV Schedule
CNBC Podcasts
CEO Interviews
CNBC Documentaries
Digital Originals
Watchlist
Investing Club
Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
PRO
Pro News
Josh Brown
Mike Santoli
Calls of the Day
My Portfolio
Livestream
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Livestream
Menu
Make It
select
USA
INTL
Livestream
Search quotes, news & videos
Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics & Policy
Video
Watchlist
Investing Club
PRO
Livestream
Menu
Top News & Analysis
Health and Science
Biotech and Pharma
Health Insurance
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday
Dan Mangan
Wed, Oct 7th 2026
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia
Jenny Lee
Wed, Oct 7th 2026
Jim Cramer says Grail can run higher as FDA decision on Galleri nears
Alexa LoMonaco
Tue, Oct 6th 2026
Russian lab worker's suspected plague death leaves experts puzzled
Elsa Ohlen
Tue, Oct 6th 2026
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk
Jenny Lee
Mon, Oct 5th 2026
Health and Science
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos
Mon, Oct 5th 2026
Health and Science
Russian lab worker dies amid plague reports. Here's what we know
Mon, Oct 5th 2026
Health and Science
Russia hospitalizes almost 200 people after death from plague: Reports
Mon, Oct 5th 2026
Trending Now
1
Inflation on many everyday items was entirely due to tariffs, NY Fed says
2
Trump bought up to $25 million in Meta and millions in SpaceX debt in August
3
America shut out Chinese EVs. Britain welcomed them — and now faces a difficult choice
4
Trump says he doesn't want Iran deal as U.S. reportedly prepares for 'massive bombing'
5
Trump's former defense secretary sees no end in sight for Iran war — to the benefit of America's 'greatest adversary'
More In Health and Science
CNBC Cures
BioMarin reports five-year Pompe disease data showing durable motor function
Fri, Oct 2nd 2026
Health and Science
Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s
Fri, Oct 2nd 2026
Health and Science
Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
Fri, Oct 2nd 2026
CNBC Cures
De-risking rare disease drug development
Thu, Oct 1st 2026
Morning Meeting
Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock
Thu, Oct 1st 2026
CNBC Work
$942 million: Insurer points finger at AI as suspect hospital charges appear
Thu, Oct 1st 2026
Tech
Grindr expands beyond dating with $250 million PurposeMed acquisition
Wed, Sep 30th 2026
Health and Science
Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial
Wed, Sep 30th 2026
Health and Science
Novo's Wegovy pill improves weight loss after people switch from injections
Wed, Sep 30th 2026
Politics & Policy
White House moves to block $810 million in funding through pocket rescission
Mon, Sep 28th 2026
Health and Science
Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
Fri, Sep 25th 2026
CNBC Cures
NIH cuts delayed a cancer trial. Patients lost time they didn't have
Tue, Oct 6th 2026
Homestretch
Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
Thu, Sep 24th 2026
Health and Science
Novo's new strategy hinges on something it can't manufacture: investor trust
Thu, Sep 24th 2026
Health and Science
Trump administration removes around 760,000 Obamacare enrollments
Tue, Sep 22nd 2026
Health and Science
Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage
Mon, Sep 21st 2026
Health and Science
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo
Mon, Sep 21st 2026
Retail
Why more companies are fighting over beauty, health and wellness spending
Fri, Sep 18th 2026
Politics & Policy
Mitch McConnell returns to Senate after three-month health absence
Tue, Sep 15th 2026
CNBC Cures
Athletes with autism take center court at the US Open
Mon, Sep 14th 2026
Health and Science
Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy
Mon, Sep 14th 2026
Health and Science
Record U.S. cyclosporiasis outbreak is over, CDC says
Fri, Sep 11th 2026
Monthly Meeting
A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now
Thu, Sep 10th 2026
CNBC Cures
Rare disease is taking his vision. A gene therapy could help — if he can get it
Thu, Sep 10th 2026
Load More
